NeoGenomics is trading 11% down at $17.02 after its CEO succession announcement weighed on sentiment.
- In its October 5 announcement, the company reported preliminary Q3 revenue of about $209 million and 28% year-over-year NGS growth.
- It kept its existing full-year guidance rather than raising it immediately.
- Warren Stone is set to take over in January 2027, while Tony Zook will become Executive Chairman. Broader markets were higher, making company-specific news the clearer catalyst.